REFERENCES
1. World Obesity Federation. World Obesity Atlas 2023. Available from: https://www.worldobesity.org/resources/resource-library/world-obesity-atlas-2023. [Last accessed on 14 Oct 2024].
2. World Health Organization. Obesity and overweigh. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. [Last accessed on 14 Oct 2024].
3. Afshin A, Forouzanfar MH, Reitsma MB, et al; GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 2017;377:13-27.
4. Stefan N, Schulze MB. Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment. Lancet Diabetes Endocrinol 2023;11:426-40.
5. Musso G, Cassader M, Cohney S, Pinach S, Saba F, Gambino R. Emerging liver-kidney interactions in nonalcoholic fatty liver disease. Trends Mol Med 2015;21:645-62.
7. Lonardo A, Mantovani A, Targher G, Baffy G. Nonalcoholic fatty liver disease and chronic kidney disease: epidemiology, pathogenesis, and clinical and research implications. Int J Mol Sci 2022;23:13320.
8. Gómez-Hernández A, Beneit N, Díaz-Castroverde S, Escribano Ó. Differential role of adipose tissues in obesity and related metabolic and vascular complications. Int J Endocrinol 2016;2016:1216783.
10. Moriconi D, Antonioli L, Masi S, et al. Glomerular hyperfiltration in morbid obesity: role of the inflammasome signalling. Nephrology (Carlton) 2022;27:673-80.
11. Moriconi D, Nannipieri M, Dadson P, Rosada J, Tentolouris N, Rebelos E. The beneficial effects of bariatric-surgery-induced weight loss on renal function. Metabolites 2022;12:967.
12. Serra A, Romero R, Lopez D, et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int 2008;73:947-55.
13. Park JY, Kim YJ. Improvement of end-stage renal disease in an obese diabetic patient after gastric bypass: bariatric times. Bariatric Times 2013;10:22-4. Available from: https://bariatrictimes.com/improvement. [Last accessed on 24 Oct 2024].
14. Park S, Kim YJ, Choi CY, Cho NJ, Gil HW, Lee EY. Bariatric surgery can reduce albuminuria in patients with severe obesity and normal kidney function by reducing systemic inflammation. Obes Surg 2018;28:831-7.
15. Schwartz P, Capotondo MM, Quaintenne M, Musso-Enz GM, Aroca-Martinez G, Musso CG. Obesity and glomerular filtration rate. Int Urol Nephrol 2023;56:1663-68.
16. Kim EY, Kim YJ. Does bariatric surgery really prevent deterioration of renal function? Surg Obes Relat Dis 2016;12:856-61.
17. D'Agati VD, Chagnac A, de Vries AP, et al. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol 2016;12:453-71.
18. Sandino J, Luzardo L, Morales E, Praga M. Which patients with obesity are at risk for renal disease? Nephron 2021;145:595-603.
19. Schütten MT, Houben AJ, de Leeuw PW, Stehouwer CD. The link between adipose tissue renin-angiotensin-aldosterone system signaling and obesity-associated hypertension. Physiology (Bethesda) 2017;32:197-209.
20. García-Carro C, Vergara A, Bermejo S, Azancot MA, Sellarés J, Soler MJ. A nephrologist perspective on obesity: from kidney injury to clinical management. Front Med (Lausanne) 2021;8:655871.
21. Artunc F, Schleicher E, Weigert C, Fritsche A, Stefan N, Häring HU. The impact of insulin resistance on the kidney and vasculature. Nat Rev Nephrol 2016;12:721-37.
22. Stasi A, Cosola C, Caggiano G, et al. Obesity-related chronic kidney disease: principal mechanisms and new approaches in nutritional management. Front Nutr 2022;9:925619.
25. Yang S, Cao C, Deng T, Zhou Z. Obesity-related glomerulopathy: a latent change in obesity requiring more attention. Kidney Blood Press Res 2020;45:510-22.
26. Kotsis V, Martinez F, Trakatelli C, Redon J. Impact of obesity in kidney diseases. Nutrients 2021;13:4482.
27. Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol 2017;12:2032-45.
28. Górriz JL, Navarro-González JF, Ortiz A, et al. Sodium-glucose cotransporter 2 inhibition: towards an indication to treat diabetic kidney disease. Nephrol Dial Transplant 2020;35:i13-23.
29. Neuen BL, Young T, Heerspink HJL, et al. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 2019;7:845-54.
30. Chagnac A, Zingerman B, Rozen-Zvi B, Herman-Edelstein M. Consequences of glomerular hyperfiltration: the role of physical forces in the pathogenesis of chronic kidney disease in diabetes and obesity. Nephron 2019;143:38-42.
31. Denic A, Glassock RJ. Obesity-related glomerulopathy and single-nephron GFR. Kidney Int Rep 2020;5:1126-8.
33. Zoja C, Abbate M, Remuzzi G. Progression of renal injury toward interstitial inflammation and glomerular sclerosis is dependent on abnormal protein filtration. Nephrol Dial Transplant 2015;30:706-12.
34. Yim HE, Yoo KH. Obesity and chronic kidney disease: prevalence, mechanism, and management. Clin Exp Pediatr 2021;64:511-8.
35. Xu T, Sheng Z, Yao L. Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment. Front Med 2017;11:340-8.
37. Martínez-Montoro JI, Morales E, Cornejo-Pareja I, Tinahones FJ, Fernández-García JC. Obesity-related glomerulopathy: current approaches and future perspectives. Obes Rev 2022;23:e13450.
38. Herman-Edelstein M, Weinstein T, Chagnac A. Obesity-related glomerulopathy: clinical management. Semin Nephrol 2021;41:358-70.
39. Friedman AN, Moe S, Fadel WF, et al. Predicting the glomerular filtration rate in bariatric surgery patients. Am J Nephrol 2014;39:8-15.
40. Scholten BJ, Persson F, Svane MS, Hansen TW, Madsbad S, Rossing P. Effect of large weight reductions on measured and estimated kidney function. BMC Nephrol 2017;18:52.
41. de Vries AP, Ruggenenti P, Ruan XZ, et al; ERA-EDTA Working Group Diabesity. Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease. Lancet Diabetes Endocrinol 2014;2:417-26.
42. Friedman AN, Schauer PR, Beddhu S, et al. Obstacles and opportunities in managing coexisting obesity and CKD: report of a scientific workshop cosponsored by the National Kidney Foundation and The Obesity Society. Am J Kidney Dis 2022;80:783-93.
43. Aboueisha MA, Evans L, Allotey JK, et al. A 5-year propensity-matched analysis of perioperative outcomes in patients with chronic kidney disease undergoing bariatric surgery. Surg Endosc 2023;37:2335-46.
44. Nguyen NT, Wolfe BM. The physiologic effects of pneumoperitoneum in the morbidly obese. Ann Surg 2005;241:219-26.
45. Filho MA, Alves RL, Nascimento PD Junior, Tarquinio GDS, Mega PF, Pinheiro Módolo NS. Effects of pneumoperitoneum on kidney injury biomarkers: a randomized clinical trial. PLoS One 2021;16:e0247088.
46. Brethauer SA, Schauer PR, Schirmer BD. Minimally invasive bariatric surgery. Springer New York; 2015. Available from: https://link.springer.com/content/pdf/10.1007/978-1-4939-1637-5.pdf. [Last accessed on 14 Oct 2024].
47. The ASMBS Textbook of Bariatric Surgery. Cham: Springer International Publishing; 2020. Available from: https://link.springer.com/book/10.1007/978-3-030-27021-6. [Last accessed on 14 Oct 2024].
48. Valera RJ, Sarmiento-Cobos M, Montorfano L, et al. Predictors and outcomes of acute kidney injury after bariatric surgery: analysis of the metabolic and bariatric surgery accreditation and quality improvement program data registry. Surg Obes Relat Dis 2023;19:1302-7.
49. Thakar CV, Kharat V, Blanck S, Leonard AC. Acute kidney injury after gastric bypass surgery. Clin J Am Soc Nephrol 2007;2:426-30.
50. Chang AR, Grams ME, Navaneethan SD. Bariatric surgery and kidney-related outcomes. Kidney Int Rep 2017;2:261-70.
51. Laurenius A, Sundbom M, Ottosson J, Näslund E, Stenberg E. Incidence of kidney stones after metabolic and bariatric surgery-data from the scandinavian obesity surgery registry. Obes Surg 2023;33:1564-70.
52. Froeder L, Arasaki CH, Malheiros CA, Baxmann AC, Heilberg IP. Response to dietary oxalate after bariatric surgery. Clin J Am Soc Nephrol 2012;7:2033-40.
53. Bhatti UH, Duffy AJ, Roberts KE, Shariff AH. Nephrolithiasis after bariatric surgery: a review of pathophysiologic mechanisms and procedural risk. Int J Surg 2016;36:618-23.
54. Guan Y, Wei X, Li J, Zhu Y, Luo P, Luo M. Obesity-related glomerulopathy: recent advances in inflammatory mechanisms and related treatments. J Leukoc Biol 2024;115:819-39.
55. He J, Xiao Y, Wang J. Potential therapeutic targets of obesity-related glomerulopathy. Metab Syndr Relat Disord 2021;19:367-71.
56. Wahab R, Cohen RV, le Roux CW. Recent advances in the treatment of patients with obesity and chronic kidney disease. Ann Med 2023;55:2203517.
57. Rogula TG, Schauer PR, Fouse T. Prevention and management of complications in bariatric surgery. Oxford University Press; 2018. Available from: https://books.google.com/books?hl=zh-CN&lr=&id=X39XDwAAQBAJ&oi=fnd&pg=PP1&dq=Prevention+and+Management+of+Complications+in+Bariatric+Surgery&ots=zLBMZvkb_-&sig=W990pbqaDCYCkZbUyxfhbnD_oyQ#v=onepage&q=Prevention%20and%20Management%20of%20Complications%20in%20Bariatric%20Surgery&f=false. [Last accessed on 14 Oct 2024].
58. Lee H, Oh S, Yang W, et al. Bariatric surgery reduces elevated urinary mitochondrial DNA copy number in patients with obesity. J Clin Endocrinol Metab 2019;104:2257-66.
59. Cañizares S, Guaillas A, Velarde F, de Vaca VC, Terán F, Caicedo A. Is bariatric surgery improving mitochondrial function in the renal cells of patients with obesity-induced kidney disease? Pharmacol Res 2022;185:106488.
60. Huang H, Lu J, Dai X, et al. Improvement of renal function after bariatric surgery: a systematic review and meta-analysis. Obes Surg 2021;31:4470-84.
62. Saliba J, Kasim NR, Tamboli RA, et al. Roux-en-Y gastric bypass reverses renal glomerular but not tubular abnormalities in excessively obese diabetics. Surgery 2010;147:282-7.
63. Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003;14:1480-6.
64. Izzedine H, Coupaye M, Reach I, Deray G. Gastric bypass and resolution of proteinuria in an obese diabetic patient. Diabet Med 2005;22:1761-2.
65. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med 2017;376:641-51.
66. Friedman AN, Wahed AS, Wang J, et al. Effect of bariatric surgery on CKD risk. J Am Soc Nephrol 2018;29:1289-300.
67. Li Z, Chen Y, Xiong J, Lyu Q, Jiang B. Renal function following bariatric surgery: a literature review of potential mechanisms. Obes Surg 2022;32:1734-40.
68. Zubiaga L, Ruiz-Tovar J. Correlation of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with metabolic parameters in patients undergoing sleeve gastrectomy. Surg Obes Relat Dis 2020;16:999-1004.
69. Kassam AF, Taylor ME, Morris MC, et al. The impact of sleeve gastrectomy on renal function in patients with chronic kidney disease varies with severity of renal insufficiency. Surg Obes Relat Dis 2020;16:607-13.
70. Johnsen EM, Sidhu G, Chen J, Moore R, Le Jemtel T, Samson R. Roux-en-Y gastric bypass and sleeve gastrectomy for obesity-associated hypertension. J Investig Med 2021;69:730-5.
71. Hou CC, Shyu RS, Lee WJ, Ser KH, Lee YC, Chen SC. Improved renal function 12 months after bariatric surgery. Surg Obes Relat Dis 2013;9:202-6.
72. Imam TH, Fischer H, Jing B, et al. Estimated GFR before and after bariatric surgery in CKD. Am J Kidney Dis 2017;69:380-8.
73. Billeter AT, Zumkeller M, Brock J, et al. Obesity surgery in patients with end-stage organ failure: is it worth it? Surg Obes Relat Dis 2022;18:495-503.
74. Sheetz KH, Woodside KJ, Shahinian VB, Dimick JB, Montgomery JR, Waits SA. Trends in bariatric surgery procedures among patients with ESKD in the United States. Clin J Am Soc Nephrol 2019;14:1193-9.
75. Pané A, Claro M, Molina-Andujar A, et al. Bariatric surgery outcomes in patients with chronic kidney disease. J Clin Med 2023;12:6095.
76. Pané A, Molina-Andujar A, Olbeyra R, et al. Bariatric surgery outcomes in patients with kidney transplantation. J Clin Med 2022;11:6030.
77. Fernando S, Varma J, Dengu F, Menon V, Malik S, O'Callaghan J. Bariatric surgery improves access to renal transplantation and is safe in renal failure as well as after transplantation: a systematic review and meta-analysis. Transplant Rev (Orlando) 2023;37:100777.
78. Potrykus M, Czaja-Stolc S, Małgorzewicz S, Proczko-Stepaniak M, Dębska-Ślizień A. Diet management of patients with chronic kidney disease in bariatric surgery. Nutrients 2022;15:165.
79. Bruci A, Tuccinardi D, Tozzi R, et al. Very low-calorie ketogenic diet: a safe and effective tool for weight loss in patients with obesity and mild kidney failure. Nutrients 2020;12:333.
80. Watanabe M, Tuccinardi D, Ernesti I, et al. Scientific evidence underlying contraindications to the ketogenic diet: an update. Obes Rev 2020;21:e13053.
81. Moriconi E, Camajani E, Fabbri A, Lenzi A, Caprio M. Very-low-calorie ketogenic diet as a safe and valuable tool for long-term glycemic management in patients with obesity and type 2 diabetes. Nutrients 2021;13:758.
82. Majorowicz RR, Attia A, Bamlet HM, et al. Nutritional considerations for patients with renal failure undergoing sleeve gastrectomy. J Ren Nutr 2024;34:76-86.
83. Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by american association of clinical endocrinologists/American college of endocrinology, the obesity society, American society for metabolic and bariatric surgery, obesity medicine association, and american society of anesthesiologists. Obesity (Silver Spring) 2020;28:O1-58.
84. Tabesh MR, Maleklou F, Ejtehadi F, Alizadeh Z. Nutrition, physical activity, and prescription of supplements in pre- and post-bariatric surgery patients: a practical guideline. Obes Surg 2019;29:3385-400.
85. Fouque D, Vennegoor M, ter Wee P, et al. EBPG guideline on nutrition. Nephrol Dial Transplant 2007;22 Suppl 2:ii45-87.
86. Favre G, Schiavo L, Lemoine S, Esnault VLM, Iannelli A. Longitudinal assessment of renal function in native kidney after bariatric surgery. Surg Obes Relat Dis 2018;14:1411-8.
87. Ben-Porat T, Weiss-Sadan A, Rottenstreich A, et al. Nutritional management for chronic kidney disease patients who undergo bariatric surgery: a narrative review. Adv Nutr 2019;10:122-32.
